GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Moat Score

Euroapi (XPAR:EAPI) Moat Score : 4/10 (As of Jun. 22, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Moat Score?

Euroapi has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Euroapi has Narrow Moat: Euroapi SA has a discernible but modest moat due to its specialized pharmaceutical manufacturing capabilities and some proprietary technologies. However, it faces significant competition and lacks strong brand strength or customer loyalty, limiting its moat to a narrow category.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Euroapi might have Narrow Moat - Discernible but modest moat.

Competitive Comparison of Euroapi's Moat Score

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroapi's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Moat Score distribution charts can be found below:

* The bar in red indicates where Euroapi's Moat Score falls into.


;
;

Euroapi  (XPAR:EAPI) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Euroapi Moat Score Related Terms

Thank you for viewing the detailed overview of Euroapi's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroapi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (XPAR:EAPI) » Definitions » Moat Score
Comparable Companies
XPAR:BOI XPAR:AB XPAR:MLCOT XPAR:ALRPD XPAR:VETO ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR
Traded in Other Exchanges
EAPIF:USA 0EAP:UK 940:Germany
Address
15 rue Traversiere, Paris, FRA, 75012
Website
https://www.euroapi.com
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines